Johnson & Johnson Unusual Options Activity

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson &…

A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson.

Looking at options history for Johnson & Johnson (NYSE:JNJ) we detected 13 strange trades.

If we consider the specifics of each trade, it is accurate to state that 38% of the investors opened trades with bullish expectations and 61% with bearish.

From the overall spotted trades, 3 are puts, for a total amount of $148,961 and 10, calls, for a total amount of $377,694.

What’s The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $140.0 to $190.0 for Johnson & Johnson over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for Johnson & Johnson’s options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Johnson & Johnson’s whale activity within a strike price range from $140.0 to $190.0 in the last 30 days.

Johnson & Johnson Option Volume And Open Interest Over Last 30 Days

Options Call Chart

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
JNJ PUT SWEEP BEARISH 06/16/23 $160.00 $79.1K 6.8K 419
JNJ CALL TRADE BULLISH 06/16/23 $160.00 $57.7K 6.9K 233
JNJ CALL TRADE BULLISH 06/16/23 $155.00 $50.5K 1.4K 75
JNJ CALL TRADE BULLISH 06/16/23 $155.00 $47.2K 1.4K 192
JNJ CALL TRADE BULLISH 01/19/24 $140.00 $44.3K 489 24

Where Is Johnson & Johnson Standing Right Now?

  • With a volume of 1,038,795, the price of JNJ is down -0.31% at $161.8.
  • RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
  • Next earnings are expected to be released in 70 days.

What The Experts Say On Johnson & Johnson:

  • Morgan Stanley has decided to maintain their Equal-Weight rating on Johnson & Johnson, which currently sits at a price target of $183.
  • Atlantic Equities has decided to maintain their Neutral rating on Johnson & Johnson, which currently sits at a price target of $167.
  • Morgan Stanley has decided to maintain their Equal-Weight rating on Johnson & Johnson, which currently sits at a price target of $179.
  • Raymond James has decided to maintain their Outperform rating on Johnson & Johnson, which currently sits at a price target of $181.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Johnson & Johnson, Benzinga Pro gives you real-time options trades alerts.

Total
0
Shares
Related Posts
Read More

Jim Cramer: This Industrial Stock Is Doing ‘Very Well’; Here’s His Take On Palantir

Jim Cramer likes Enbridge Inc. (NYSE: ENB), says Lazard, Inc. (NYSE: LAZ) is a good buy, and Advanced Drainage Systems, Inc. (NYSE: WMS) is an incredible infrastructure play. He also mentions Jacobs Solutions Inc. (NYSE: J) and Sarepta Therapeutics, Inc. (NASDAQ: SRPT). Petrobras CEO was fired by Brazil's President, and Palantir Technologies Inc. (NYSE: PLTR) reported a 21% increase in first-quarter revenue.

ASTS

Read More

Levi Strauss Likely To Report Sharp Drop In Q2 Earnings; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts

Levi Strauss & Co. (NYSE: LECI) is expected to report its financial results for the second quarter ended May 28, 2023, after the closing bell on July 6, 2023. Analysts expect the company to post quarterly earnings at 3 cents per share, down from year-ago earnings of 23 cents per share. The company’s revenue might come in at $1.34 billion.

LECI